CNM-Au8 ® treatment demonstrated significantly reduced plasma neurofilament light chain (NfL) levels compared to placebo at 24 weeks (p=0.04) Clene (CLNN) plans to discuss the totality of the survival ...
In the intent to treat analysis, Dermata saw statistically significant differences in IGA treatment success, inflammatory lesion count, and non-inflammatory lesion count at week 4 (earliest measured ...
How can physicians, in the care of their patients, translate research findings into useful information? P-values suggest differences, not effects. But could there be a simple solution? One of the ...
Post-operative radiotherapy (PORT) used in patients with non-small-cell lung cancer (NSCLC) following complete resection and after (neo) adjuvant chemotherapy shows no statistically significant ...
There is a statistically significant difference between what the exit polls say happened in the 2016 Presidential Election and what the vote totals say happened on November 8th. Alone this proves ...
The study suggests that adding a Bruton tyrosine kinase inhibitor (BTKi) to frontline chemoimmunotherapy in Richter ...
A higher maternal HIV load in pregnancy is linked toward earlier onset of puberty in HIV-exposed and uninfected boys but not girls.
- Dermata previously announced XYNGARI(TM) produced highly statistically significant topline data for all primary endpoints at week 12 in Phase 3 trial - - Additional data analysis revealed that ...
Dermata Therapeutics (DRMA) announced that additional analysis of topline data from its Phase 3 STAR-1 trial showed that XYNGARI had a statistically significant difference from placebo on three ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback